No phaseRecruiting
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Comparing the Efficacy and Safety of the EndoZipTM System and Apollo Endoscopic Sleeve Gastroplasty (ESG), Followed by Behavioral Modifications, in Obese Patients Who Have Not Achieved Weight Reduction Through Non-surgical Methods.
- Sponsor
- Nitinotes Surgical Ltd. (Industry)
- Enrolment
- 184 planned
- Conditions
- Obesity; Overweight
- Interventions
- EndoZip System; OverStitch Endoscopic Suturing System (ESG)
- Ages
- adults, older adults
- Registry
- NCT07090005
Full record on ClinicalTrials.gov
From the registry
evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
Primary outcomes
- Mean percent of total body weight loss (%TBWL) after 12 months in Group A patients versus Group B.
- Percentage of patients in Group A with a reduction in %TBWL of at least 5% at 12 months
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered